Its a wonder how Drug regulatory agencies of the West act in such an abstract manner! The approved 700 Generic formulations of various Indian pharma companies over a periood of 10 years [ 2004 to 2014 ] and with a single decision ban these all together in one day! Does this mean that over the past 10 long years, millions of patients in the European countries received these formulations which according to the regulators were not tested in an appropriate manner. The regulators must now let people know what harm could have been done to those unsuspecting patients who took these medicines, over ten long years, with the confidence that these were approved by the regulators concerned, so that these patients can claim compensation from the regulatory agencies involved.The Drugs Controller General of India should grant a blanket approval to all these 700 "GENERIC" formulations for sale at reduced prices in India. This will help Indian patients immensely as they will get the cheaper "GENERIC" drugs rather than spending a fortune on the costly "BRANDED"versions of the same drugs. It will also help the Indian Pharma companies involved to prevent their monetary losses suffered due to this ban. It is the Indian patients who need cheaper "GENERIC" drugs and not the patients fro Europe or USA. The DCGI can take this opportunity to weed out "BRANDED GENERICS" proliferated by the Indian Pharma companies and offer only cheaper "GENERIC" formulations of drugs to the teeming poor population in India.